Dianthus Therapeutics (DNTH) Revenue (2022 - 2025)
Dianthus Therapeutics (DNTH) reported Revenue of $396,000 for Q3 2025, down 81.8% from $2.17 million a year earlier but up 105.2% from the prior quarter.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Revenue (2022 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Dianthus Therapeutics' Revenue came in at $3.08 million, down 42.6% year-over-year; for FY2024, it was $6.24 million, up 120.6% from FY2023.
- By year, Revenue came in at $2.83 million in FY2023 (-78.0%) and $12.82 million in FY2022.
- Five-year quarterly Revenue spans a low of $193,000 in Q2 2025 and a high of $7.58 million in Q4 2022.
- Year over year, Revenue gained in three of the last eight quarters, with growth averaging 9.6%.
- The high point for year-over-year Revenue in five years was Q4 2024 (growth of 190.2%); the low point was Q4 2023 (a decline of 94.0%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $193,000 (Q2 2025), $1.16 million (Q1 2025) and $1.33 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Dianthus Therapeutics | 3.76 Bn | 3.71 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 396,000.00 |
| Jun 30, 2025 | 193,000.00 |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Sep 30, 2024 | 2.17 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 874,000.00 |
| Dec 31, 2023 | 457,000.00 |
| Sep 30, 2023 | 924,000.00 |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 976,000.00 |
| Dec 31, 2022 | 7.58 Mn |
| Sep 30, 2022 | 1.17 Mn |
API Access
Dianthus Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();